Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1514 of 6351
-
Could a diabetes pill protect eyesight in advanced dry AMD?
Disease control Recruiting nowAMD is a leading cause of blindness in individuals over 50 years old, with dry AMD being the most common form. Geographic atrophy (GA) is an advanced stage of dry AMD characterized by progressive retinal cell degeneration. The primary objectives of the study are to assess the saf…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New hope for Alzheimer's agitation: Long-Term safety trial underway
Symptom relief Recruiting nowThe purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzhei…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New drug duo aims to shrink tough tumors
Disease control Recruiting nowThis study aims to evaluate the safety and preliminary efficacy of SHR-7367 in combination with antineoplastic agents in subjects with advanced solid tumors, and to determine the maximum tolerated dose (MTD) and the recommended Phase II dose (RP2D).
Phase 1/2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New shot aims to tackle hidden heart risk: high lp(a)
Disease control OngoingThe main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New ultrasound tool could spare heart attack patients a second procedure
Diagnosis Not yet recruitingBrief Summary The Purpose of the Study : The purpose of this study is to find a safe and reliable "one-stop" solution for treating heart attack patients who have multiple blocked arteries. Currently, doctors face a dilemma: Testing these other blockages during the heart attack pr…
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Heart-Smart surgery: new approach may shield Kids' brains during moyamoya procedure
Disease control Recruiting nowThis prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease.…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New antibody targets FGFR1 to fight metastatic cancers
Disease control Recruiting nowOne of the most relevant targets in the field of novel targeted anticancer therapy is the family of receptors to fibroblast growth factor receptors (FGFRs). FGFR1 is the main representative of the FGFR family. The goal of this clinical trial is to learn if monoclonal anti-FGFR1 …
Phase 1/2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo therapy takes on tough myeloma
Disease control Recruiting nowThis is a single-arm, open-label, phase 1b study evaluating the safety and feasibility of using talquetamab as bridging therapy prior to cilta-cel in patients with relapsed and refractory multiple myeloma (RRMM).
Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New antibody drug JMT108 enters human trials for tough cancers
Disease control Recruiting nowThe goal of this clinical trial is to test JMT108, a type of drug called a bispecific antibody in adult patients with locally advanced or metastatic solid tumors. The main questions it aims to answer are: * To assess the safety and tolerability of JMT108 at increasing doses and…
Phase 1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowPhase 1b/2 open-label study evaluates the safety, tolerability, and efficacy of combination immunotherapy with nadunolimab (anti-IL-1RAP) and toripalimab (anti-PD-1) in patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer. Phase 1b will a…
Phase 1/2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a daily pill replace hormone shots for prostate cancer?
Disease control Recruiting nowHypothesis The use of Abiraterone 250 mg with food + prednisone, without LHRH analogs or blockers (ADT), achieves castration-level testosterone at 30 days in ≥80-90% of cases.
Phase 2 • Sponsor: SMED Clinical Research • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a common amino acid fix Stroke-Related balance problems?
Symptom relief Recruiting nowAlong with the current clinical trial, the efficacy and safety of 4 gram of acetyl-leucine daily for three months in patients with post-stroke ataxia following posterior-circulation ischaemic stroke assessed through BBS, SARA, and mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for lymphoma patients: mosunetuzumab under review
Disease control Recruiting nowRetrospective, multicenter observational study to evaluate the response to treatment with Mosunetuzumab in relapsed/refractory Follicular Lymphoma (FL) after at least three lines of therapy, within the Compassionate Use Program (CUP).
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New rabies vaccine could cut shots from three visits to one
Vaccine Not yet recruitingThis is a phase II randomised, open-label study to assess the safety and immunogenicity of coadministration of the candidate rabies vaccine ChAdOx2 RabG and licensed vaccine in healthy adults (18-45 years old). ChAdOx2 RabG will be administered intramuscularly and licensed rabies…
Phase 2 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 07:57 UTC
-
New cocktail of drugs aims to shrink Hard-to-Treat abdominal tumors
Disease control Not yet recruitingAssuming that the objective response rate (ORR) of neoadjuvant chemotherapy in patients with colorectal cancer peritoneal metastasis is approximately 0.40 , a total sample size of 30 patients is required. Step 1: Ten patients will be initially enrolled. If the number of respond…
Phase 2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Smart radiation: daily adjustments may spare prostate cancer patients from side effects
Symptom relief Recruiting nowThis clinical trial studies the side effects of image-guidance and online adaptation with stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate adenocarcinoma that has not spread to other parts of the body (localized). Image-guided SBRT is a stand…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New hope for advanced prostate cancer: combination therapy enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety of the combination therapy of Lutetium (177Lu) DGUL and pembrolizumab. It will also assess the antitumor efficacy and pharmacokinetics of the combination therapy compared to Lutetium (177Lu) DGUL monotherapy. Participants…
Phase 1 • Sponsor: Cellbion Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI coach helps heart patients get fit at home
Disease control Recruiting nowThe goal of this clinical trial is to find out if an artificial intelligence (AI)-enabled stratified management platform can help adults with coronary heart disease (CHD) better perform exercise rehabilitation and manage their health after being discharged from the hospital. The …
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Sweat it out: High-Intensity workouts may boost language recovery after stroke
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the effects of a high-intensity exercise program on recovery in individuals with post-stroke aphasia. The high-intensity exercise program has been specifically designed for individuals with post-stroke aphasia and includes an interva…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New pill aims to tame dangerous phosphate in kidney patients
Disease control Recruiting nowA clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.
Phase 3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC